YARAL Pharma Inc.

Expanding Access to Quality Generics.
Committed to Exceptional Service.

YARAL Pharma Inc. is the US subsidiary of IBSA, a global pharmaceutical company headquartered in Switzerland. By focusing on people and innovating the ways they’re cared for, YARAL Pharma is proud to offer the same values and expertise of its parent company to the US market.

Dedicated to ensuring access to affordable authorized generics (AGs) and complex generic medicines that enhance healthcare outcomes, YARAL Pharma offers its customers high-quality products across a range of therapeutic areas, continuity of supply, and a commitment to exceptional customer service.

Available now, YARAL Pharma’s lead product, Diclofenac Epolamine Topical System 1.3%, backed by more than 30 years of clinical experience. 


Our Mission

YARAL Pharma is dedicated to ensuring access to high quality, affordable authorized generics (AG) and complex generic medicines to enhance healthcare outcomes.


A patient-centered approach, always remembering to value the person beyond the disease and give full attention to what patients want and need.


Create quality by simplifying existing therapeutic solutions through innovative formulas and systems. Quality is the common denominator of all our activities.


Innovate upon existing therapeutic solutions with the goal of creating treatment tools that are simpler and yet more advanced.


Respond to treatment needs in a way that goes beyond the concept of disease.

Scroll to Top